Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1972 2
1976 1
1979 3
1980 1
1983 2
1985 3
1986 2
1987 2
1988 1
1989 1
1990 1
1991 3
1992 3
1993 5
1994 8
1995 4
1996 5
1997 8
1998 8
1999 5
2000 5
2001 10
2002 14
2003 11
2004 8
2005 15
2006 4
2007 11
2008 16
2009 8
2010 14
2011 14
2012 15
2013 9
2014 23
2015 20
2016 23
2017 18
2018 24
2019 10
2020 19
2021 26
2022 19
2023 13
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

367 results

Results by year

Filters applied: . Clear all
Page 1
Olfactory Neuroblastoma.
Veyrat M, Vérillaud B, Fiaux-Camous D, Froelich S, Bresson D, Nicolai P, Herman P. Veyrat M, et al. Adv Otorhinolaryngol. 2020;84:154-167. doi: 10.1159/000457935. Epub 2020 Jul 30. Adv Otorhinolaryngol. 2020. PMID: 32731231 Review.
Based on Hyams grading, studies have pointed out that grades III-IV entail significantly different behavior and prognosis. A multimodal approach, which may combine surgery, chemotherapy, and radiotherapy, is essential to manage these tumors. ...The role of neoadjuvant chem …
Based on Hyams grading, studies have pointed out that grades III-IV entail significantly different behavior and prognosis. A multimod …
Oncology for the rhinologist.
Tam K, Dunn LA, Cohen MA. Tam K, et al. Curr Opin Otolaryngol Head Neck Surg. 2024 Feb 1;32(1):14-19. doi: 10.1097/MOO.0000000000000951. Epub 2023 Dec 6. Curr Opin Otolaryngol Head Neck Surg. 2024. PMID: 38116847 Review.
RECENT FINDINGS: Historically, patients with locally advanced SNMs have had relatively poor prognoses and high morbidity from treatment. The available retrospective data suggests that induction chemotherapy may improve outcomes for patients with sinonasal undifferentiated …
RECENT FINDINGS: Historically, patients with locally advanced SNMs have had relatively poor prognoses and high morbidity from treatme …
Esthesioneuroblastoma.
Ow TJ, Bell D, Kupferman ME, Demonte F, Hanna EY. Ow TJ, et al. Neurosurg Clin N Am. 2013 Jan;24(1):51-65. doi: 10.1016/j.nec.2012.08.005. Neurosurg Clin N Am. 2013. PMID: 23174357 Review.
The role for chemotherapy is not defined, but is generally for the most advanced cases and used in the neoadjuvant setting and/or postoperatively with irradiation. Prognosis is favorable; however, metastasis rates remain relatively high. ...
The role for chemotherapy is not defined, but is generally for the most advanced cases and used in the neoadjuvant setting and/or postoperat …
Update on olfactory neuroblastoma.
Lopez F, Agaimy A, Franchi A, Suárez C, Vander Poorten V, Mäkitie AA, Homma A, Eisbruch A, Olsen KD, Saba NF, Nuyts S, Snyderman C, Beitler JJ, Corry J, Hanna E, Hellquist H, Rinaldo A, Ferlito A. Lopez F, et al. Virchows Arch. 2024 Apr;484(4):567-585. doi: 10.1007/s00428-024-03758-z. Epub 2024 Feb 22. Virchows Arch. 2024. PMID: 38386106 Review.
Due to the paucity of large-scale studies, standardisation of diagnosis, treatment and prediction of outcome remains a challenge. Surgical resection by endoscopic techniques with the addition of postoperative irradiation is the treatment of choice. ...
Due to the paucity of large-scale studies, standardisation of diagnosis, treatment and prediction of outcome remains a challenge. Sur …
Esthesioneuroblastoma.
Elkon D, Hightower SI, Lim ML, Cantrell RW, Constable WC. Elkon D, et al. Cancer. 1979 Sep;44(3):1087-94. doi: 10.1002/1097-0142(197909)44:3<1087::aid-cncr2820440343>3.0.co;2-a. Cancer. 1979. PMID: 383268 Review.
Stage C patients have a poor prognosis, with 52.9% surviving 3 years. Treatment consisted of radiotherapy, surgery, or a combination of radiotherapy and surgery. In stage A, prognosis is favorable in all three treatment groups with one 1 of 24 patients dying of recu …
Stage C patients have a poor prognosis, with 52.9% surviving 3 years. Treatment consisted of radiotherapy, surgery, or a combination …
Of mice and men: olfactory neuroblastoma among animals and humans.
Lubojemska A, Borejko M, Czapiewski P, Dziadziuszko R, Biernat W. Lubojemska A, et al. Vet Comp Oncol. 2016 Sep;14(3):e70-82. doi: 10.1111/vco.12102. Epub 2014 Jul 12. Vet Comp Oncol. 2016. PMID: 25041470 Review.
Olfactory neuroblastoma (ONB) is a rare tumour of nasal cavity and paranasal sinuses that arises from the olfactory neuroepithelium and has unpredictable clinical course. As the sense of smell is phylogenetically one of the first senses and olfactory neuroepithelium is evo …
Olfactory neuroblastoma (ONB) is a rare tumour of nasal cavity and paranasal sinuses that arises from the olfactory neuroepithelium and has …
Diagnosis and management of esthesioneuroblastoma.
Bradley PJ, Jones NS, Robertson I. Bradley PJ, et al. Curr Opin Otolaryngol Head Neck Surg. 2003 Apr;11(2):112-8. doi: 10.1097/00020840-200304000-00009. Curr Opin Otolaryngol Head Neck Surg. 2003. PMID: 14515089 Review.
Neck metastases, when they present, should be excised using a modified neck dissection. Distant metastases may present at any time during the course of the disease, generally within 36 months, and may respond to local radiotherapy or systemic chemotherapy. ...
Neck metastases, when they present, should be excised using a modified neck dissection. Distant metastases may present at any time during th …
Esthesioneuroblastoma: prognosis and management.
Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Morita A, et al. Neurosurgery. 1993 May;32(5):706-14; discussion 714-5. doi: 10.1227/00006123-199305000-00002. Neurosurgery. 1993. PMID: 8492845
Their clinical manifestations and treatment results were reviewed to identify possible prognostic factors. The 5-year survival rate for all patients was 69%. ...The pathological grade of the tumor was the most significant prognostic factor identified. The 5-year sur …
Their clinical manifestations and treatment results were reviewed to identify possible prognostic factors. The 5-year survival rate f …
Paranasal sinus cancer.
Bridger GP, Mendelsohn MS, Baldwin M, Smee R. Bridger GP, et al. Aust N Z J Surg. 1991 Apr;61(4):290-4. doi: 10.1111/j.1445-2197.1991.tb00214.x. Aust N Z J Surg. 1991. PMID: 2018438
Aesthesioneuroblastoma.
Koka VN, Julieron M, Bourhis J, Janot F, Le Ridant AM, Marandas P, Luboinski B, Schwaab G. Koka VN, et al. J Laryngol Otol. 1998 Jul;112(7):628-33. doi: 10.1017/s0022215100141295. J Laryngol Otol. 1998. PMID: 9775291
Distant metastases commonly occurred in bone (82 per cent). Cervical metastasis was an unfavourable prognostic indicator (0 per cent survival at two years). In conclusion, aesthesioneuroblastoma is sensitive to chemotherapy and radiotherapy. ...
Distant metastases commonly occurred in bone (82 per cent). Cervical metastasis was an unfavourable prognostic indicator (0 per cent …
367 results